SCCR27: Asia Pacific Group outlines its position on the broadcast treaty and copyright L&Es
The Republic of Korea delivered the following statement outlining the position of the Asia Pacific Group (a large and diverse group of Member States including but not limited to Bangladesh, India, Indonesia, Iran, the Republic of Korea and Singapore).
Asia Pacific Group Statement for SCCR 27- finalThank you Mr. Chairman
Good morning dear colleagues.
Mr. Chairman,
I have the honour to deliver this statement on behalf of Asia Pacific group.
Mr. Chairman,
SCCR27: US position on the Scope of Application (Article 6) of the proposed Broadcasting Treaty
The WIPO Standing Committee on Copyright and Related Rights (SCCR27) is currently discussing Article 6 (Scope of Application) of the working text of the proposed Treaty on the Protection of Broadcasting Organizations (SCCR/27/2).
The United States of America delivered this nuanced intervention on the Scope of Application.
KEI opposes negotiations at WIPO on a broadcasting treaty
KEI comment to SCCR 27 on the proposed Broadcasters Treaty
KEI is a non-profit organization representing consumer and public interests and seeking better outcomes for knowledge governance.
KEI opposes continued discussions in the SCCR on the treaty for broadcasting, for the following reasons.
1. The broadcasting organizations have failed to explain (a) the problem the treaty is supposed to address, (b) how the proposed text is related to the alleged problem.
29 April 2014: The Tunis Model Law on Copyright for Developing Countries: Is it Time for an Update?
On Tuesday, 29 April 2014, Knowledge Ecology International (KEI) will convene a panel at WIPO headquarters entitled, The Tunis Model Law on Copyright for Developing Countries: Is it Time for an Update?
US Policy Making Transparency: A Good Example and a Really Bad Example
This short note is about giving people the heads up about four upcoming USPTO public meetings relating to copyright policy making: re remixes, digital first sale and calibration of statutory damages. It is a good example of ONE US agency (PTO is within a Task Force) wisely seeking “additional input from the public in order for the Task Force to have a complete and thorough record upon which to make recommendations.” But this blog post is also about a really bad example: USTR.
SCCR27: UK proposal on the Proposed WIPO treaty on the protection of broadcasting organizations (the BBC experience)
On 8 April 2014, the United Kingdom of Great Britain and Northern Ireland submitted a paper to the 27th session of WIPO’s Standing Committee on Copyright and Related Rights (SCCR) on the Proposed WIPO treaty on the protection of broadcasting organizations (SCCR/27/3). In its proposal, the UK endeavors to “shed light on a number of different technologies already being used by broadcasters from around the world” including the deployment of the BBC iPlayer and the BBC Red Button services.
32 Members of US House of Representatives ask USTR to sanction Canada for not granting patents on drugs
The attached letter, dated April 10, 2014 and signed by a bipartisan group of 32 members of the House of Representatives, asks USTR to elevate Canada to the Special 301 “priority watch list,” for “violation of their international obligations” for not granting enough patents on “innovative medicines.” According to the members of Congress signing the letter, Canada is in violation of its WTO TRIPS obligations. Continue Reading
On the Table for the next Standing Committee on Copyright and Related Rights (SCCR27) April 28 to May 2
What is on the table for the next Standing Committee on Copyright and Related Rights: Twenty-Seventh Session (SCCR/27) April 28 to May 2, 2014 (Geneva, Switzerland)?
KEI comment on ViiV license to Medicines Patent Pool for HIV drug dolutegravir (DTG)
On April 1, 2014, ViiV, a consortium of Pfizer and GSK, and the Medicines Patent Pool (MPP), announced two new licensing agreements that expand generic competition for dolutegravir (DTG), and integrase inhibitor used for the treatment of adult and pediatric HIV infection. (MPP press release here.) Dolutegravir is a new drug, approved for marketing by the US FDA on August 12, 2013. Continue Reading
Leaked EU analysis of TTIP IPR negotiations
Below is a two page excerpt from a March 20, 2014 EU analysis of the TransAtlantic Trade and Investment Partnership (TTIP) negotiations on intellectual property rights, including geographical indications. The memo summarizes in a sentence or two the negotiations in eight types of intellectual property, patents, copyrights, designs, pharmaceutical regulatory test data, plant varieties, trademarks, trade secrets, geographical indications (GIs), as well as negotiations on enforcement, voluntary best practices, and cooperation on third country and multilateral IPR negotiations. Continue Reading